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Abstract. The process of wound healing can be divided 
into substrate, proliferative, and remodeling phases. The 
basic biologic and physiologic events which transpire 
during these stages are examined in detail. Particular em- 
phasis is placed on the interactions between platelets, 
macrophages, and other inflammatory cells, and fibro- 
blasts in the healing wound. Recent advances in the roles 
played by interleukins, fibronectin, and epidermal growth 
factor are discussed. 
Production and healing of cutaneous defects are two 
of the most important biologic events in the practice 
of dermatology. A thorough understanding of the 
molecular events of wound healing and their sub- 
sequent biologic effects is therefore essential in both 
general dermatology and dermatologic surgery. 
The physiologic process of wound healing can be 
divided temporally into three separate phases: sub- 
strate phase, proliferative phase, and remodeling phase 
(Fig. 1). The substrate phase is so named because of 
its cellular and other interactions within the milieu 
of the wound which lead to preparation of the wound 
for subsequent events. It encompasses the first 3 to 
4 days after wounding, and is characterized by vas- 
cular and inflammatory components. During this 
time, inflammatory cells and fibrin are exuded, im- 
parting temporary stability to the healing wound. 
The proliferative phase, which occurs over the next 
10 to 14 days, is dominated by proliferation of fi- 
broblasts and the subsequent synthesis of collagen. 
The final phase of wound healing, the remodeling 
phase, takes place over a period of 6 to 12 months 
or longer. During this time, collagen formed during 
the proliferative phase is eventually replaced by a 
more stable form of collagen. There is a dynamic 
equilibrium between the synthesis of stable colla- 
gen and lysis of immature collagen. To better un- 
derstand the process of wound healing, an in-depth 
review of these three basic phases and their inter- 
actions is in order. 
THE SUBSTRATE PHASE 
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Immediately after injury, hemostasis is achieved by 
active constriction of locally damaged blood ves- 
sels, as well as aggregation of platelets to form a 
hemostatic plug.' Upon exposure to biologically 
mature collagen and probably other connective tis- 
sue components, platelets adhere to the collagen 
and aggregate with each other.* Proline and hy- 
droxyproline are perhaps the most important de- 
terminants in recognition of collagen by platelets, 
as deamination or blocking of these free amino 
groups on the collagen molecule decreases platelet 
a g g r e g a t i ~ n . ~  However, the mechanism by which 
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broblast is also attributed to this growth factor. Al- 
though mitosis in early wound repair could be ex- 
plained by this platelet-derived growth factor, 
continued mitogenesis 10 to 12 days later (after 
platelets no longer have access to the tissue) cannot 
be attributed to this factor. Leibovich and Ross" 
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FIGURE 1. The three phases of wound healing. Note that 
the substrate phase encompasses both vascular and in- 
flammatory components. 
the collagen-platelet interaction takes place has not 
yet been well elucidated. It has been postulated but 
not proven that attachment of platelets to collagen 
is facilitated by platelet membrane f ibr~nect in .~ It 
has long been known that after contacting collagen, 
platelets undergo transformation into activated 
bodies, some of which exhibit long p s e ~ d o p o d s . ~ , ~  
Platelets possess organelles which degranulate dur- 
ing aggregation, releasing several factors including 
adenosine diphosphate (ADP), thromboxane A,, and 
5-hydroxytryptamine. These substances potentiate 
further aggregation of platelets augmenting for- 
mation of the vascular plug.' 
A second, separate process also contributes to 
formation of the clot at the site of injury. Injured 
cells in the wound release thromboplastin (clotting 
factor 111), which activates the extrinsic coagulation 
mechanism. This cascade eventually results in the 
cleavage of prothrombin into thrombin. Thrombin 
in turn cleaves fibrinogen into fibrin monomers 
which polymerize to form a fibrin network.' 
Platelets are also active (directly and indirectly) 
in influencing leukocyte chemotaxis. They release 
proteolytic enzymes that are responsibile for initi- 
ation of the alternate complement pathway. Com- 
plement component C5a is chemotactic for the cells 
which will be important in later events during heal- 
Leukocyte chemotaxis is probably also en- 
hanced by 12-hydroxyeicosatetraenoic acid (12- 
HETE),6 which is elaborated from arachidonic acid 
by 12-lipoxygenase, and is released by platelets upon 
their contact with collagen.' Platelet-derived 12-hy- 
droperoxyeicosatraenoic acid (12-HPETE) and 
platelet activating factor induce production of leu- 
kotriene B,, probably the major chemotactic agent, 
by neutrophils.' 
Serum contains a platelet-derived mitogen nec- 
essary for the proliferation of fibroblast and smooth 
muscle cells in culture.' This growth factor is a heat- 
stable protein that stimulates DNA synthesis in cul- 
tured human cells.'0 An increase in general protein 
synthesis (including collagen synthesis) by the fi- 
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Crete a growth factor in vitro which stimulates fi- 
broblast proliferation. It is not known whether this 
mitogen is identical or similar to the growth factor 
produced by platelets, but it is likely that the 
macrophage-derived growth factor is responsible for 
the continued mitogenesis later in wound healing. 
Plasma contains other proteins which are impor- 
tant in this phase of healing. Activated Hageman 
factor (coagulation factor XIIa) acts through the 
prekallikrein-kallikrein system to cause activation 
of plasminogen, and generation of bradykinin. This 
last substance is probably active in several func- 
tions, including increased vascular permeability and 
leukocyte chemotaxis. In addition, factor XIIa con- 
tributes to activation of factor XI, beginning the 
clotting cascade. The ensuing cascade of events ul- 
timately results in formation of thrombin.12 As in 
the extrinsic pathway, thrombin cleaves fibrinogen 
into fibrin monomers which polymerize to form a 
fibrin network.' This fibrin scaffolding provides three 
important functions. Besides imparting temporary 
stability to the wound defect, the coagulum pro- 
vides continued hemostasis, and a framework over 
which fibroblasts and epithelial cells can later mi- 
grate. 
As a result of the chemotactic factors, neutro- 
phils, the first participant cell in the inflammatory 
component of the substrate phase, appear in the 
wound at approximately six hours after wounding 
(Fig. 2). They reach a maximum number at 1 to 2 
days and decline after approximately 2 to 3 days in 
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FIGURE 2. Sequence of inflammatory cells in wound heal- 
ing. Neutrophils are the first cells to appear in the wound, 
followed by macrophages and lymphocytes. 
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the absence of i n fe~ t ion . '~ , ' ~  Neutrophils do not 
stimulate fibroplasia, but initiate bacterial ingestion 
and wound debridement. Damaged polymorpho- 
nuclear leukocytes aid macrophages in debride- 
ment by releasing proteolytic, collagenolytic, and 
fibrinolytic enzymes into the local environment. 
Despite these functions, it has been shown that re- 
pair in neutropenic animals proceeds normally in 
the absence of in fe~t ion . '~  
The role of lymphocytes in the process of wound 
healing remains controversial, although their role 
may be more significant than initially appreciated. 
Lymphocytes are at their maximum number in the 
wound at approximately day 6 of healingI3 (Fig. 2). 
Perhaps the most important function of lympho- 
cytes in wound healing is the ability of a specific 
subset of T-cells to synthesize lymphokines, a group 
of soluble humoral mediators. Two of the factors, 
macrophage migration inhibition factor (MIF) and 
macrophage activation factor (MAF), are of partic- 
ular importance. MIF is a glycoprotein, molecular 
weight 20,000 to 40,000, which attracts macro- 
phages to the area of inflammation and retains them 
at that site. MAF activates macrophages, enhancing 
their various functions as described below.I6 Lym- 
phocytes also release chemotactic factors for neu- 
trophils, eosinophils, basophils, and other lympho- 
cytes, but these factors are probably not vital to 
wound healing, since granulocytes appear earlier 
in the healing wound. Lymphokines have also been 
shown to stimulate fibroblast migration and prolif- 
eration, as well as collagen and noncollagen protein 
synthesis. l7  
It has recently been suggested that several pre- 
viously described lymphokines are similar, if not 
identical substances. T-cell growth factor, thymo- 
cyte mitogenesis factor, thymocyte-stimulating fac- 
tor, and killer cell helper factor are now grouped 
under the term interleukin 2.18,'9 This 15,000 dalton 
protein, produced by helper T-cel l~, '~  induces the 
proliferation of thymocytes after they have been 
stimulated by exposure to antigens." Analogous to 
the consolidation of nomenclature of lymphokines, 
monokines, previously known as lymphocyte-acti- 
vating factor and B-cell activation factor, are now 
known as interleukin l . I 9  Produced by macro- 
phages, this 15,000 dalton protein has been shown 
to have stimulatory effects on proliferation of thy- 
mocytes and synthesis of l y m p h o k i n e ~ . ' ~ , ~ ~  In ad- 
dition to its direct stimulatory effects on thymo-' 
cytes, interleukin 1 probably affects proliferation of 
fibroblasts and granulocytes. 18,20 This substance, 
which may be identical to the macrophage endog- 
enous pyrogen, has also been found to promote in- 
terleukin 2 biosynthesis and secretion. Recently, it 
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has been shown that keratinocytes produce a sub- 
stance identical in composition and function to in- 
terleukin 1. This product has been named epider- 
mal thymocyte activation factor (ETAF). 
Macrophages, which are derived from circulating 
monocytes, are perhaps the most important inflam- 
matory cell in wound healing. These are the only 
cells which can tolerate the low oxygen tensions at 
the leading edge of the wound. They have a rela- 
tively long life span and generally appear in the 
wound during the first 5 days (Fig. 2 ) .  Unlike heal- 
ing in the absence of lymphocytes and neutrophils, 
wound repair suffers dramatically from monocyto- 
penia.21 Migration of monocytes into the wound area 
may be stimulated by numerous substances, in- 
cluding collagen fragments, plasma, fibronectin 
fragments, lymphokines, bacterial endotoxins, and 
complement components.22 Some of these factors 
are components of normal tissues. Perhaps at 
wounding, conversion from inactive forms allows 
these substances to exhibit chemoattractant prop- 
erties. Once macrophages are in the wound area, 
their activation may be initiated by lymphokines, 
immune complexes, complement component C3b, 
and fibronectin, all of which are important in 
macrophage activation in ~ u l t u r e . ' ~ , ~ ~  
Activated macrophages perform a number of 
functions, the foremost of which is wound debride- 
ment. Macrophages accomplish this by production 
and secretion of proteinases, such as collagenases, 
plasminogen activators, and elastases. Activated 
macrophages also exhibit augmented lysosomal 
activity24 and enhanced release of complement 
 component^.'^ These components enhance de- 
bridement by activation of further macrophages. 
Macrophages influence both collagen synthesis 
and lysis." Collagen degradation by macrophages 
predominates during the first 3 to 4 days of wound 
healing. Synthetic activity is stimulated between days 
7 and 10. 
The role of macrophages in neovascularization 
was proven experimentally by Thakral et a1.26 They 
found that addition of macrophages to the wound 
on the second day after wounding-which is two 
to three days before these cells are seen under 
physiological conditions-led to ingrowth of new 
vessels two to three days earlier than in control cir- 
cumstances. 
Although eosinophils have been found to have 
collagenase activity, their role in wound healing is 
probably limited. The number of eosinophils peaks 
between days 7 and 14, during the period of intense 
collagen formation and remodeling. Therefore, they 
could play a role in collagen rem~del ing.~ '  
Along with the intricate roles played by the vari- 
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ous inflammatory cells, another substance, fibro- 
nectin, has been found to be of vital importance in 
wound repair. Fibronectin is localized in the clot in 
association with individual strands of fibrin as early 
as 5 days after wounding. This 440,000 dalton 
glycoprotein, also known as large external trans- 
formation sensitive (LETS) protein or cell surface 
protein (CSP), is produced by many types of dif- 
ferentiated cells, including fibroblasts, endothelial 
cells, and hepatocytes.28 
Many important functions have been attributed 
to fibronectin. Mononuclear cells are coated by this 
substance, aiding in both opsonization and phag- 
ocytosis by these ~ e l l s . ~ ~ , ~ ~  It is also found on the 
surface of the cultured fibroblasts, suggesting an 
adhesive role between these cells and the extracel- 
lular matrix. Fibronectin probably plays a role in 
tissue adhesion at junctions between the epidermis 
and the dermis, as well as between endothelial cells 
and the dermis, due to its ability to cross-link with 
collagen and glycosaminoglycans.29 Other impor- 
tant processes in which fibronectin participates in- 
clude blood coagulation, cellular differentiation, and 
production of a provisional substrate essential for 
cell migration and pr~liferation.~' 
Elegant work by Clark et al.31 has shown that 
fibronectin associated with reepithelialization is de- 
rived mainly from plasma early in wound repair, 
and from both plasma and fibroblasts in the later 
phases. They have postulated that fibroblasts mi- 
grate along the fibronectin matrix in a tractor-tread 
fashion. This mechanism consists of an interaction 
between intracellular contractile microfilaments 
(actin) of fibroblasts with an extracellular microfil- 
ament (fibronectin) through a plasma membrane 
linkage (Fig. 3). The fibroblasts actively move along 
the fibronectin scaffolding. Migrating epidermal cells 
also contain intracellular microfilaments near their 
inner plasma membrane, and may migrate over the 
fibronectin matrix in a similar fashion.31 
Fibronectin is also found in normal skin. Here it 
is a component of the basement membane region 
of hofh the epidermis and blood vessels.32 There is 
little fihonectin associated with papillary dermal 
collagen, and virtually none in the reticular der- 
mis. 29 
It appears that fibronectin has a much stronger 
affinity for type I11 collagen than for the more ma- 
ture type I collagen. However, it binds strongly to 
all forms of denatured collagen, and this may ac- 
tually account for the small proportion of type I 
collagen with which it interacts. Adhesion of fibro- 
blasts to fibrin is potentiated by the cross-linkage 
of fibrin to f i b r ~ n e c t i n . ~ ~ , ~ ~  Binding of fibronectin to 
denatured collagen may be important in the re- 
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FIGURE 3. Diagrammatic representation of extracellular 
contractile mechanism involving fibronectin, and fibro- 
blasts or epithelial cells. Fibroblasts and epithelial cells 
migrate along the fibronectin matrix in a tractor-tread 
fashion. 
moval of collagen during remodeling, as the bind- 
ing promotes phagocytosis by both fibroblasts and 
macro phages. 28,34 
THE PROLIFERATIVE PHASE 
The ultimate objective of the vascular and inflam- 
matory aspects of the substrate phase is to prepare 
the defect for repair. The proliferative phase, which 
occurs over the ensuing 10 to 14 days, results in 
regeneration of the epidermis, neoangiogenesis, and 
proliferation of fibroblasts leading to collagen syn- 
thesis. 
Approximately 12 hours after wounding, epider- 
mal cells adjacent to the wound become somewhat 
flattened and develop pseudopod-like extensions of 
their cytoplasm.35 Within 24 hours, cells 1 to 2 mm 
from the wound margin begin to migrate into the 
wound. Migration occurs only over viable tissue, 
and its rate is directly proportional to the tissue- 
oxygen tension, being highest in hyperbaric con- 
ditions. In an optimal environment, the rate of cell 
movement is approximately 12 to 21 p.m per hour, 
equivalent to two to three cell diameters per hour. 
Epidermal cells are guided in their migration by the 
scaffolding of the underlying fibrin network.36 The 
cells burrow under crusts, if present, since a moist 
environment is necessary for their migration.35 They 
appear to move by a combination of individual cell 
ameboid motion and mass movement in sheets by 
rolling or sliding over one a n ~ t h e r . ~ '  The desmo- 
somes between cells at this point are smaller and 
fewer in number than those in resting cells. Fila- 
ments measuring 40-80 angstroms that have been 
shown to fix antiactin antibodies also develop at the 
periphery of the migrating epithelial cells. As pre- 
viously stated, these filaments may align with ex- 
tracellular microfilaments (fibronectin) to establish 
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a tractor-tread apparatus responsible for locomo- 
tion. These contractile proteins disappear after 
healing, and are not present in intact normal epi- 
dermis. 
Basement membrane zone changes occur be- 
neath migrating epidermal cells. The basal lamina 
dissolves, and two basement membrane proteins, 
type IV collagen and laminin, disappear. These two 
basement membrane proteins mediate epithelial cell 
adhesion to the underlying dermis under normal 
circumstances. In their place, an irregular, thick- 
ened provisional matrix containing fibrin and fibro- 
nectin forms under the proliferating epidermal cells. 
This fibronectin complex promotes migration of fi- 
broblasts and endothelial cells as well as migrating 
epidermal cells. Approximately 7 to 9 days after 
wounding, the basement membrane zones loses its 
thickened appearance, fibronectin and fibrin dis- 
appear, and type IV collagen and laminin reap- 
pear.37 
Alexander has shown that in open wound mar- 
gins, epidermal cells are elongated with the long 
axis of the cell parallel to the wound defect. He has 
found that the cytoplasmic organelles are polar- 
ized, with the epidermal nuclei pointing toward the 
open wound, which is also the direction of cell 
movement (Fig. 4). The Golgi complex trails, pos- 
sibly secreting material which contributes to for- 
mation of the glycosaminoglycan cell coat.38 Inclu- 
sion bodies (probably phagolysosomes), as well as 
a prominent rough endoplasmic reticulum, also ap- 
pear in the migrating epithelial cells. 
Mitosis in the intact epidermis has a diurnal 
rhythm, being greatest during periods of inactivity. 
This rhythm is lost shortly after wounding, reach- 
ing a peak at approximately 48 hours, when activity 
may be increased 17-f0ld.~~ The source of the epi- 
dermal cells varies with the characteristics of the 
wound. In deep wounds, cells must migrate from 
the peripheral edges. In shallow wounds, however, 
reepithelialization may also occur from epidermal 
cells in the skin appendages, such as hair follicles. 
This is why healing shallow wounds may clinically 
appear to have buds of new epidermis. 
When migrating epithelial cells meet in the cen- 
ter of the wound, they form desmosomal attach- 
ments and resume normal morphology and func- 
tion. The rate of epithelial cell mitosis then falls to 
approximately three to four times the normal rate. 
This phenomenon, whereby epidermal cells revert 
to their pre-wound status, has been termed contact 
inhibi t i~n,~ '  and is probably due to physical contact 
of cells with similar cells from the other side of the 
wound. 
Currently under investigation is the role played 
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FIGURE 4. Diagrammatic representation of migrating epi- 
dermal cells in the wound. The cytoplasmic organelles 
are polarized, with the nucleus pointing toward the open 
wound, and the Golgi complex trailing. 
by a heat-stable polypeptide, epidermal growth fac- 
tor (EGF), with a molecular weight of approxi- 
mately 15,700 in humans. The sites of synthesis of 
this protein factor are not known, but it has been 
isolated from urine, breast milk, saliva, salivary gland 
and amniotic fluid, and is present in epidermis. It 
has been shown that human EGF is biologically 
equivalent, and probably chemically identical to the 
gastric antisecretory hormone u r ~ g a s t r o n e . ~ ~  In the 
presence of EGF, increased mitogenesis is observed 
in epithelial cell culture. Contact inhibition is some- 
times absent in these cultures, leading to epithelial 
hypertrophy and hyperplasia. The mechanisms by 
which EGF enhances cell growth and division are 
unknown, although protein phosphorylation at ty- 
rosine residues is probably an important compo- 
nent.42 Actions of EGF on the epidermis include 
increased transport of nutrients from the environ- 
ment into the cell; increased activity of glycolysis; 
increased rate of protein, DNA, and RNA synthe- 
sis; and activation of certain enzymes such as or- 
nithine decarboxylase. Other processes which seem 
to be affected by EGF include activation of protein 
phosphorylation, enhanced biosynthesis of pros- 
taglandins E, and F2a,43 changes in properties of the 
plasma membrane, increased keratinization of the 
epidermis, and biosynthesis of f i b r ~ n e c t i n . ~ ~ , ~ ~  
EGF binds to a specific cell surface receptor, 
causing an increase in membrane phosphorylation. 
This is believed to be the initial intracellular bio- 
chemical signal generated by formation of the EGF/ 
receptor complex. After binding to the cell surface, 
the EGFireceptor complex is internalized by endo- 
cytosis in a fashion similar to that which occurs with 
other polypeptide hormones. The actual mecha- 
nism by which the biological responses of EGF are 
generated is unknown. It is assumed that the ef- 
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fects are probaby due to direct interaction of EGF 
with the epidermis rather than through a second 
hormone.44 
At the same time that the epidermis is regener- 
ating, capillary buds from nearby vessels in the 
wound form an anastomosing network. Knighton 
and Hunt45 have postulated that hypoxic conditions 
in the central dead space of the wound enhance the 
release of growth factors for macrophages, the only 
cell which can tolerate severe hypoxia. These growth 
factors are also capable of stimulating angiogenesis. 
When the oxygen tension increases after new vas- 
cular channels have provided blood to these dead 
spaces, the release of these growth factors is inhib- 
ited, in turn causing cessation of capillary growth. 
As the oxygen demands for collagen synthesis de- 
crease, these newly formed vascular channels re- 
gress, leading to an avascular, cell-free scar. 
As the epidermis and underlying vasculature are 
regenerating, changes in the dermis are also taking 
place which will result in repair of the dermal de- 
fect. Fibroblasts begin to appear in the wound to- 
ward the end of the inflammatory phase, beginning 
at 48 to 72 hours. Once this migration occurs, an 
additional 2 days elapse before active collagen syn- 
thesis is evident, this period being termed the "lag 
phase."46 The origin of the fibroblasts is uncertain. 
Probably several types of mesenchymal cells are ca- 
pable of differentiating into fibroblasts under ap- 
propriate conditions. Experiments with bone mar- 
row transplants performed by Stewart et a1 have 
shown that wound fibroblasts are of local tissue or- 
igin, in contrast to the wound macrophages which 
are derived from hemopoietic tissue.47 
Movement of fibroblasts is similar to that of epi- 
dermal cells. The fibroblasts adhere to underlying 
collagen and fibrin which are coated by fibronectin. 
As outlined earlier, the fibroblasts pull themselves 
along the fibronectin matrix by contraction of intra- 
cellular contractible microfilaments. Their replica- 
tion is potentiated in areas of relatively low oxygen 
tension (30 to 40 mm Hg). Therefore, replication is 
greatest in front of the advancing capillary arcade 
in the center of the wound. As the new vessels bring 
increased oxygen tension to the environment, rep- 
lication of fibroblasts decreases, and biosynthesis 
of collagen, which requires increased oxygen con- 
centration, begins.48 
The major metabolic functions of fibroblasts are 
the synthesis of collagen, proteoglycans, and elas- 
tin. For optimal fibroblastic activity, a mildly acidic 
medium is necessary. This is provided by accu- 
mulation of lactate from anaerobic metabolism in 
the wound. A reducing medium, provided by as- 
corbic acid, and oxygen tensions of at least 10 to 20 
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torr are also necessary. Lower oxygen levels impede 
formation of collagen by a decrease in oxidative me- 
tabolism. Oxygen is also required for hydroxyla- 
tion, which is important in collagen synthesis. 
Synthesis of collagen by fibroblasts begins by as- 
sembly of polypeptide chains at the polyribosomes. 
The molecular formula of each polypeptide chain 
can be represented as (GLY-x-y), where x is fre- 
quently represented by proline and y by 4-hydroxy- 
proline. The presence of glycine in every third 
position is crucial for spacial orientation of the mol- 
ecule and is responsible for the left-handed helical 
configuration of each individual chain.49 Hydroxy- 
proline accounts for approximately 10% of the total 
collagen molecule. After hydroxylation, three heli- 
cal chains are twisted around each other into a right- 
handed superhelix within the cisternae of the en- 
doplasmic reticulum. Formation of both intra-chain 
and inter-chain disulfide bonds in the propeptide 
then occurs.49 After secretion of procollagen from 
fibroblasts, proteases cleave the procollagen mole- 
cule into collagen extracellularly. The collagen then 
self-assembles into fibrils. Finally, lysyl oxidase 
converts some lysine and hydroxylysine residues 
into aldehyde derivatives that form cross-links with 
similar residues in adjacent molecules, thus im- 
parting mechanical stability to the collagen fiber.49 
A prominent type of collagen formed early in the 
wound is type I11 collagen, which consists of three 
identical polypeptide chains.50 This form of colla- 
gen, which is associated with a gel-like consistency, 
first appears approximately 2 to 3 days after injury, 
and is maximally synthesized between days 5 and 
7. 
O'Hare et al.51 have recently reported five fac- 
tors, with presently unknown chemical natures, 
which have been found to stimulate the activity of 
prolyl hydroxylase, an important enzyme in colla- 
gen polypeptide synthesis. These collagen-stimu- 
lating factors also stimulate general protein synthe- 
sis, but to a much lesser extent. Such factors have 
been found to be increased in concentration signif- 
icantly at day 2 when fibroblast activity first ap- 
pears, and they reach a maximum concentration at 
day 3, immediately prior to maximal fibroblastic ac- 
t i ~ i t y . ~ '  In addition, macrophages also secrete fac- 
tors, including lactates, as a result of their lytic ac- 
tivity. These macrophage factors also have a 
stimulatory factor on fibroblastic activity. 
Although collagen represents greater than 50% 
of the newly formed scar, this new connective tis- 
sue also contains glycosaminoglycans and proteo- 
g l y ~ a n s . ~ ~ , ~ ~  These substances are formed at the same 
time as collagen, with maximum synthesis at 2 weeks 
after wounding. The proteoglycans and glycosa- 
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minoglycans function in controlling salt and water 
concentrations in connective tissue. These mole- 
cules may also be directly involved in cell-cell and 
cell-matrix  interaction^.^^ 
THE REMODELING PHASE 
The total amount of collagen reaches a maximum 2 
to 3 weeks after wounding. Despite this, there is a 
progressive increase in the tensile strength of the 
wound for up to 1 year or more. This increase, al- 
though steady and progressive, produces a wound 
which is never more than 80% as strong as the orig- 
inal skin. In fact, at 2 weeks after wounding, when 
sutures are often removed, the wound has regained 
only 5% of its original strength, increasing to only 
40% at 1 month.55 
It is during this period, the remodeling phase, 
that the original collagen gel, synthesized in the 
first few weeks of wound healing, is replaced by a 
more stable interwoven type collagen. During this 
transition, type 111 collagen is gradually replaced by 
type I collagen. Water and glycosaminoglycans are 
lost from the wound leading to compression of the 
collagen fibers. Closer approximation of the fibers 
allows increased cross-linking by covalent bond for- 
mation, lending greater stability to the fibers.56 Re- 
modeling also results in reorientation of the fiber 
alignment in the scar. Those collagen fibrils which 
escape degradation by collagenases are generally 
those which are initially laid down parallel to the 
lines of tension. 
The remodeling phase represents a dynamic 
equilibrium between synthesis of new, and lysis of 
old, collagen. Collagen resorption is tissue-specific 
and strictly regulated by various collagenases. Be- 
fore the collagenases can exert their activity, aux- 
iliary enzymes, such as hyaluronidase and other 
proteases, must expose the fibrils, removing other 
noncollagen substances (protein-polysaccharide 
complexes) which are associated with collagen in 
connective t i s s ~ e . ~ ’  
There are three types of enzymes that have the 
ability to digest collagen. One of these is bacterial 
collagenase, such as that produced by Clostridium. 
Another type is the group of lysosomal proteases, 
such as cathepsins. These proteases usually act on 
fragments which have previously been digested and 
phagocytized. Finally, and perhaps the most im- 
portant enzyme in collagen degradation during 
wound healing, there is tissue collagenase. All tis- 
sue collagenases behave in the same general man- 
ner. They require calcium for function, as it has 
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been shown that their action is inhibited by chelat- 
ing agents such as EDTA.58 
Tissue collagenases are synthesized by several 
cell types. In the skin, collagenase is found in the 
superficial layers of the papillary dermis. However, 
only tissues that contain epithelial cells show sig- 
nificant collagenolytic activity. It is therefore pos- 
tulated that a mesenchymal-epithelial interaction is 
necessary for collagenase synthesis. Tissues rich in 
mesenchymal, epithelial, and inflammatory cells 
show the greatest synthetic activity of collagen- 
a ~ e . ~ ’ , ~ ’  
Macrophages have also been observed to secrete 
collagenase after being activated by endotoxins or 
l y m p h ~ k i n e s . ~ ~  Polymorphonuclear leukocytes also 
produce collagenases as well as neutral proteases, 
both of which become significant when these cells 
persist, as in chronic infection. Leukocyte collagen- 
ases are not tissue-specific, and the neutral pro- 
teases are capable of digesting basement membrane 
material as well as collagen. Fibronectin is partic- 
ularly vulnerable to the neutral proteases produced 
by polymorphonuclear leukocytes. These enzymes 
undoubtedly play a role in dehiscence of wounds 
during infection.60 
Wound contraction, the final stage of healing, 
begins 1 week after wounding. This is the time that 
the inflammatory response is declining and con- 
nective tissue proliferation is reaching a peak. Con- 
traction progresses at a rate of approximately 0.6 to 
0.7 mdday,  independent of wound size. The shape 
of full-thickness defects does influence the rate, 
however. Round wounds do not contract as quickly 
or completely as rectangular or stellate defects. 
Contraction is not due to excessive deposition of 
collagen, as this is a rigid structural protein with 
no innate contractability. Also, this process can oc- 
cur without significant collagen formation, as shown 
by experimentally inducing scurvy in animals. These 
animals could not synthesize new collagen, yet 
wound contraction continued to occur.61 
The contractile forces produced by granulation 
tissue in wounds are derived from modified fibro- 
blasts which contain contractile proteins.62 These 
fibroblasts are converted into myofibroblasts by 
undergoing structural, compositional, immunolog- 
ical, and functional changes. Electron microscopy 
reveals characteristics of both fibroblasts and smooth 
muscle cells. These myofibroblasts contain abun- 
dant rough endoplasmic reticulum due to their ac- 
tive collagen synthesis. Microtubules are also 
prominent, performing a bracing function. Myofi- 
broblasts contain a large amount of contractile pro- 
tein. In fact, granulation tissue contains as much 
actomyosin as an equivalent weight of smooth mus- 
1. Dermatol. Surg. Oncol. 12:11 November 1986 
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~ l e . ~ ~  Contraction of the myofibroblasts has been 
shown to be inhibited by smooth muscle relaxants. 
Therefore, these cells share not only histologic but 
functional features of smooth muscle cells. Myofi- 
broblasts are joined to one another. These cell-to- 
cell attachments allow the myofibroblasts to pull 
upon one another during their migration over the 
neomatrix, and transmit contraction from cell to cell. 
These cells are distributed throughout the wound 
and are not concentrated at the edges of the con- 
tracting wound.61 
These final processes involved in wound remod- 
eling and contraction lead to a scar which shares 
many features with the preexisting normal skin, 
producing a functional, healed wound. It is when 
the orchestrated events described above are de- 
ranged or disturbed that hypertrophic or other ab- 
normal scars are formed. 
SUMMARY 
Healing of cutaneous wounds is an intricately or- 
chestrated array of events which can be divided into 
three phases. Important in the substrate phase are 
platelets and their products, complement and in- 
flammatory cells, including lymphocytes, neutro- 
phils, and macrophages. Activated macrophages may 
be the most important cells in this phase of healing, 
contributing to wound debridement, release of 
complement components, synthesis and degrada- 
tion of collagen, and neoangiogenesis, among other 
functions. 
The second phase of healing, the proliferative 
phase, finds epidermal cells migrating over a scaf- 
folding of fibrin and fibronectin which has replaced 
the normal, thinner basement membrane zone. Epi- 
dermal growth factor is important in this step, al- 
though its exact mechanisms remain to be ex- 
plained. New blood vessels supply much of the 
nutrition for healing at this phase. Fibroblasts are 
activated, forming collagen for the dermal compo- 
nent of the wound. 
The final phase, that of remodeling, is character- 
ized by a dynamic continuation of collagen synthe- 
sis and degradation. Degradation is accomplished 
by collagenase derived from several sources. As these 
events proceed, myofibroblasts effect wound con- 
traction. 
Wound healing is therefore a predictable, auto- 
matic chain of events eventuating in a relatively 
avascular scar in place of a cutaneous defect. Fur- 
ther manipulation of the final outcome of wound 
healing by the physician may be accomplished with 
1. Derrnatol. Surg. Oncol. 12:11 November 1986 
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